A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Cancer|Metastatic Cancer|Breast Cancer
Interventions: DRUG: ART4215|DRUG: Talazoparib|DRUG: Niraparib
Sponsor: Artios Pharma Ltd